These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 3504500)
21. Polymer-coated microparticles for the sustained release of nitrofurantoin. Liu J; Chan SY; Ho PC J Pharm Pharmacol; 2002 Sep; 54(9):1205-12. PubMed ID: 12356274 [TBL] [Abstract][Full Text] [Related]
22. Preparation and characteristics of microcapsules containing enoxacin by one continuous process of agglomeration and microencapsulation. Ueda M; Nakamura Y; Makita H; Kawashima Y J Microencapsul; 1993; 10(2):171-80. PubMed ID: 8331491 [TBL] [Abstract][Full Text] [Related]
23. Formulation and in vitro and in vivo availability of diclofenac sodium enteric-coated beads. Hosny EA; el-Mahrouk GM; Gouda MW Drug Dev Ind Pharm; 1998 Jul; 24(7):661-6. PubMed ID: 9876511 [TBL] [Abstract][Full Text] [Related]
24. Influence of acrylic esters and methacyrlic esters on flotation of pellets and release rate of verapamil hydrochloride. Lunio R; Sawicki W Acta Pol Pharm; 2006; 63(1):69-74. PubMed ID: 17515332 [TBL] [Abstract][Full Text] [Related]
25. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928 [TBL] [Abstract][Full Text] [Related]
26. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289 [TBL] [Abstract][Full Text] [Related]
27. Controlled release microspheres based on Eudragit L100 for the oral administration of erythromycin. Morishita I; Morishita M; Machida Y; Nagai T Drug Des Deliv; 1991 Jul; 7(4):309-19. PubMed ID: 1930622 [TBL] [Abstract][Full Text] [Related]
29. Comparative bioavailability of two capsule formulations of mefenamic acid. Rawashdeh NM; Najib NM; Jalal IM Int J Clin Pharmacol Ther; 1997 Aug; 35(8):329-33. PubMed ID: 9266288 [TBL] [Abstract][Full Text] [Related]
30. Stabilization of a supersaturated solution of mefenamic acid from a solid dispersion with EUDRAGIT(®) EPO. Kojima T; Higashi K; Suzuki T; Tomono K; Moribe K; Yamamoto K Pharm Res; 2012 Oct; 29(10):2777-91. PubMed ID: 22219167 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of the sustained release properties of Eudragit RS, RL and S (acrylic resins) microcapsules containing ketoprofen in beagle dogs. Goto S; Kawata M; Nakamura M; Nagatsuma Y; Fujinaga K; Aoyama T J Microencapsul; 1988; 5(4):343-60. PubMed ID: 3236155 [TBL] [Abstract][Full Text] [Related]
32. [Experimental study of acrylic resin coated gentamicin tablets for local antibiotic therapy]. Hanamura T Nihon Seikeigeka Gakkai Zasshi; 1984 Jun; 58(6):555-65. PubMed ID: 6491422 [TBL] [Abstract][Full Text] [Related]
33. Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets. Hu LD; Liu Y; Tang X; Zhang Q Eur J Pharm Biopharm; 2006 Oct; 64(2):185-92. PubMed ID: 16797948 [TBL] [Abstract][Full Text] [Related]
34. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55. Sauer D; Zheng W; Coots LB; McGinity JW Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929 [TBL] [Abstract][Full Text] [Related]
35. Influence of ammonia solution on gastric mucosa and acetic acid induced ulcer in rats. Hata M; Yamazaki Y; Ueda T; Kato T; Kohli Y; Fujiki N Eur J Histochem; 1994; 38(1):41-52. PubMed ID: 7517730 [TBL] [Abstract][Full Text] [Related]
36. Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets. Ceballos A; Cirri M; Maestrelli F; Corti G; Mura P Farmaco; 2005; 60(11-12):913-8. PubMed ID: 16129436 [TBL] [Abstract][Full Text] [Related]
37. Studies of chitosan/organic acid/Eudragit RS/RL-coated system for colonic delivery. Kaur K; Kim K Int J Pharm; 2009 Jan; 366(1-2):140-8. PubMed ID: 18835342 [TBL] [Abstract][Full Text] [Related]
38. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin. Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137 [TBL] [Abstract][Full Text] [Related]
39. Dissolution behaviour of sustained release formulations of indomethacin with Eudragit RS. Khanfar MS; Salem MS; Najib NM; Pillai GK Acta Pharm Hung; 1997 Nov; 67(6):235-9. PubMed ID: 9423295 [TBL] [Abstract][Full Text] [Related]
40. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease. Rainsford KD; Stetsko PI; Sirko SP; Debski S J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]